Emotional and Social Loneliness in Individuals with and Without Substance Dependence Disorder
Overview
Affiliations
Background: Loneliness is one of the psychological variables related to high risk behaviors that should be investigated more.
Objectives: The current study aimed to assess emotional, social, romantic, and familial dimensions of loneliness in drug abuser and nondrug abuser individuals.
Patients And Methods: Two hundred and twenty eight individuals were enrolled in this cross sectional study. Hundred and eighteen drug abusers were recruited through random sampling among the clients referred to Baharan Psychiatric Hospital, and 110 non-substance dependent individuals were selected from their companions, students, and staffs. In addition to clinical interview, the Iranian short version of the social and emotional loneliness scale for adults (SELSA-S) was used to evaluate the participants.
Results: There were statistically significant difference between the scores of all four emotional, social, familial, and romantic dimensions of loneliness in substance dependent individuals. Although there was no difference between the scores of men and women, the mean scores of romantic and emotional dimensions were higher in non-substance dependent women.
Conclusions: The feeling of loneliness is stronger in drug abusers rather than non-drug abusers that could develop the sense of being different from community and increase the probability of taking high risk behaviors and abusing drugs. Thus, it is suggested to consider the feeling of loneliness in all programs designed to prevent or treat addiction.
Increased threat learning after social isolation in human adolescents.
Towner E, Thomas K, Tomova L, Blakemore S R Soc Open Sci. 2024; 11(11):240101.
PMID: 39539503 PMC: 11557247. DOI: 10.1098/rsos.240101.
Csikos V, Dora F, Lang T, Darai L, Szendi V, Toth A Cells. 2024; 13(12.
PMID: 38920671 PMC: 11201939. DOI: 10.3390/cells13121043.
Ross E, Jimenez D, Ghanooni D, Mendez A, Hirshfield S, Horvath K Int J Behav Med. 2024; .
PMID: 38684565 PMC: 11518875. DOI: 10.1007/s12529-024-10288-0.
Wah T, Ong A, Naidu K, Hanafi S, Tan K, Tan A Subst Abuse Treat Prev Policy. 2024; 19(1):23.
PMID: 38627809 PMC: 11020317. DOI: 10.1186/s13011-024-00605-x.
Evaluation of heroin-assisted treatment in Norway: protocol for a mixed methods study.
Myklebust L, Eide D, Arnevik E, Dadras O, De Pirro S, Ellefsen R BMC Health Serv Res. 2024; 24(1):398.
PMID: 38553691 PMC: 10981318. DOI: 10.1186/s12913-024-10767-w.